Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dalroi who wrote (2)	4/5/2002 5:04:54 PM
From: scaram(o)uche	Read Replies (1) of 684

Richard said that these situations are hardly no-brainers, but I still consider KDUS to be such. I was buying a little VGNX yesterday at 2.21. VGNX rationale is the letter to CEO Crouch that is appended to the 10-K. Something is going to change for the better, if only that we lose the current CEO. The letter was just recently posted to the thread here at SI. The KDUS rationale is lotsa cash, licenses out for stuff, and 25% of Axiom Biotechnologies. A tomato will probaby come along and mention tax credits. The thread here at SI has all the nitty gritty. :-) Disclosure: I don't own as much KDUS as Carl Icahn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next